Gels including bioactive components
First Claim
1. A composition comprising ester-terminated dimer acid-based polyamide (ETDABP) and at least one bioactive agent, the composition having a consistency of a gel, wherein the bioactive agent is selected from the group consisting of anti-fungal agents, hemorrhoid treatment agents, anti-itching agents, wart-treatment agents, antibiotics and topical analgesics.
17 Assignments
0 Petitions
Accused Products
Abstract
An ester-terminated dimer acid-based polyamide may be blended with a solvent to form a gel. The solvent may be flammable, and a wick may be added to the resulting gel so as to form a candle. Depending on the composition, the candle may be formed into a free standing pillar, or may be better suited to being placed in a container. The solvent may be mineral oil. A solid coating may be placed around the candle, for advantages including to enhance the clarity and/or mechanical stability of the gelled body, and to eliminate the tendency of a gel to have an oily feel and to accept noticeable fingerprints. The ester-terminated dimer acid-based polyamide may also be combined with an active ingredient, such as a fragrance, colorant, insect-repellant, insecticide, bioactive ingredient or the like, to afford a delivery vehicle for the active ingredient.
177 Citations
24 Claims
- 1. A composition comprising ester-terminated dimer acid-based polyamide (ETDABP) and at least one bioactive agent, the composition having a consistency of a gel, wherein the bioactive agent is selected from the group consisting of anti-fungal agents, hemorrhoid treatment agents, anti-itching agents, wart-treatment agents, antibiotics and topical analgesics.
-
2. A composition comprising ester-terminated dimer acid-based polyamide (ETDABP) and at least one bioactive agent, the composition having a consistency of a gel, wherein the bioactive agent is selected from the group consisting of acetylsalicylic acid, acyclovir, 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid, amphotericin B, ascorbic acid, benzoyl peroxide, betamethasone valerate, chloroxylenol, citric acid, clindamycin phosphate, clobetasol propionate, clotrimazole, cyproheptadine, diclofenac, diphenylhydramine hydrochloride, econazole, erthromycin, estradiol, glycolic acid, glycyrrhetinic acid, hydrocortisone, hydroquinone, ibuprofen, ketoconazole, kojic acid, lactic acid, lidocaine hydrochloride, metronidazole, miconazole, miconazole nitrate, octopirox, 5-n-octanoylsalicylic acid, paracetamol, pramoxine hydrochloride, progesterone, retinoic acid, retinol, salicylic acid, superoxide dismutases, terbinafine, thenaldine, α
- -tocopherol, tolnaftate, trimeprazine, 1,8,10-tripropionyl-9-anthrone, undecylenate, and vitamin D.
- View Dependent Claims (11, 12, 13, 14, 15, 16, 17)
- 3. A composition comprising ester-terminated dimer acid-based polyamide (ETDABP) and at least one bioactive agent, the composition having a consistency of a gel, wherein the bioactive agent is an antibiotic.
Specification